Open access · CC-BY
via OpenAlex
The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells
Gérald J. Prud’homme, Yelena Glinka, Mervé Kurt, Wenjuan Liu, Qinghua Wang
Biochemical and Biophysical Research Communications · 2017 · ▲ 49 citations
Abstract
Systemic gamma-aminobutyric acid (GABA) therapy prevents or ameliorates type 1 diabetes (T1D), by suppressing autoimmune responses and stimulating pancreatic beta cells. In beta cells, it increases insulin secretion, prevents apoptosis, and induces regeneration. It is unclear how GABA mediates these effects. We hypothesized that Klotho is involved. It is a multi-functional protein expressed in the kidneys, brain, pancreatic beta cells, other tissues, and is cell-bound or soluble. Klotho knockout mice display accelerated aging, and in humans Klotho circulating levels decline with age, renal disease and diabetes. Here, we report that GABA markedly increased circulating levels of Klotho in streptozotocin (STZ)-induced diabetes. GABA also increased Klotho in the islet of Langerhans of normal mice, as well as the islets and kidneys of STZ-treated mice. In vitro, GABA stimulated production and secretion of Klotho by human islet cells. Knockdown (KD) of Klotho with siRNA in INS-1E insulinoma cells abrogated the protective effects of GABA against STZ toxicity. Following KD, soluble Klotho reversed the effects of Klotho deficiency. In human islet cells soluble Klotho protected against cell death, and stimulated proliferation and insulin secretion. NF-κB activation triggers beta-cell apoptosis, and both GABA and Klotho suppress this pathway. We found Klotho KD augmented NF-κB p65 expression, and abrogated the ability of GABA to block NF-κB activation. This is the first report that GABAergic stimulation increases Klotho expression. Klotho protected and stimulated beta cells and lack of Klotho (KD) was reversed by soluble Klotho. These findings have important implications for the treatment of T1D.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.bbrc.2017.10.029
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Prud’homme, G.J., Glinka, Y., Kurt, M., Liu, W., & Wang, Q. (2017). The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells. <em>Biochemical and Biophysical Research Communications</em>. https://doi.org/10.1016/j.bbrc.2017.10.029
Vancouver
Prud’homme GJ, Glinka Y, Kurt M, Liu W, Wang Q. The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells. Biochemical and Biophysical Research Communications. 2017. doi:10.1016/j.bbrc.2017.10.029.
BibTeX
@article{grald2017Theant,
title = {The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells},
author = {Gérald J. Prud’homme and Yelena Glinka and Mervé Kurt and Wenjuan Liu and Qinghua Wang},
journal = {Biochemical and Biophysical Research Communications},
year = {2017},
doi = {10.1016/j.bbrc.2017.10.029},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Laboratory Investigation 2002
Open access · OA
HIV-1 Envelope Glycoprotein 120 Increases Intercellular Adhesion Molecule-1 Expression by Human Endothelial Cells
American Journal of Nephrology 2011
Citation only
Indoxyl Sulfate Downregulates Renal Expression of Klotho through Production of ROS and Activation of Nuclear Factor-ĸB
Journal of Clinical Investigation 2007
Open access · OA
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Aging Cell 2021
Open access · CC-BY
Inhibition of DNA methyltransferase aberrations reinstates antioxidant aging suppressors and ameliorates renal aging
Journal of the American Society of Nephrology 2013
Citation only
Klotho to Treat Kidney Fibrosis
Alzheimer s & Dementia 2006
Open access · OA